Vaccines Against Antimicrobial Resistance
2020/06/03 by Roberto Rosini, Sonia Nicchi, Mariagrazia Pizza +1 · 1 voice · 28 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Antibiotic Resistance in Bacteria #Antibiotic Use and Resistance #Pneumonia and Respiratory Infections
paper · pdf · doi:10.3389/fimmu.2020.01048
Abstract
In the last century, life expectancy has increased considerably, thanks to the introduction of antibiotics, hygiene and vaccines that have contributed to the cure and prevention of many infectious diseases. The era of antimicrobial therapy started in the nineteenth century with the identification of chemical compounds with antimicrobial properties. However, immediately after the introduction of these novel drugs, microorganisms started to become resistant through different strategies. Although resistance mechanisms were already present before antibiotic introduction, their large-scale use and mis-use have increased the number of resistant microorganisms. Rapid spreading of mobile elements by horizontal gene transfer such as plasmids and integrative conjugative elements (ICE) carrying multiple resistance genes has dramatically increased the worldwide prevalence of relevant multi drug-resistant human pathogens such as Staphylococcus aureus, Neisseria gonorrhoeae, and Enterobacteriaceae. Today, antimicrobial resistance (AMR) remains one of the major global concerns to be addressed and only global efforts could help in finding a solution. In terms of magnitude e, economic impact of AMR is estimated to be comparable to that of climate global change in 2030. Although antibiotics continue to be essential to treat such infections, non-antibiotic therapies will play an important role in limiting the increase of antibiotic resistant microorganisms. Among non-antibiotic strategies, vaccines and therapeutic monoclonal antibodies (mAbs) play a strategic role. In this review, we will summarize the evolution and the mechanisms of antibiotic resistance, the impact of AMR on life expectancy and economics.
Citations
Cited by
- Outer Membrane Vesicle‐Coated Nanoparticle Vaccine Protects against <i>Acinetobacter baumannii</i> Pneumonia and Sepsis
- Novel and emerging antimicrobial strategies in the management of oral infections
- Antibiotic Resistance in Developing Countries: Emerging Threats and Policy Responses
- Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ. [europepmc]
- Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens. [europepmc]
- The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics. [europepmc]
- Strategies to Tackle Antimicrobial Resistance: The Example of Escherichia coli and Pseudomonas aeruginosa . [europepmc]
- Operationalising One Health in Nigeria: Reflections From a High-Level Expert Panel Discussion Commemorating the 2020 World Antibiotics Awareness Week. [europepmc]
- Fighting Antibiotic Resistance in Hospital-Acquired Infections: Current State and Emerging Technologies in Disease Prevention, Diagnostics and Therapy. [europepmc]
- The role of vaccines in combating antimicrobial resistance (AMR) bacteria. [europepmc]
- Staphylococcus aureus -A Known Opponent against Host Defense Mechanisms and Vaccine Development-Do We Still Have a Chance to Win? [europepmc]
- Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics. [europepmc]
- Designing a Recombinant Vaccine against Providencia rettgeri Using Immunoinformatics Approach. [europepmc]
- Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies. [europepmc]
- Metal-Based Nanoparticles: Antibacterial Mechanisms and Biomedical Application. [europepmc]
- CRISPR-Cas System: A Tool to Eliminate Drug-Resistant Gram-Negative Bacteria. [europepmc]
- Recent Approaches for Downplaying Antibiotic Resistance: Molecular Mechanisms. [europepmc]
- Antibiotics and Bacterial Resistance-A Short Story of an Endless Arms Race. [europepmc]
- A Comprehensive Review on Bacterial Vaccines Combating Antimicrobial Resistance in Poultry. [europepmc]
- Outer Membrane Vesicle-Coated Nanoparticle Vaccine Protects Against Acinetobacter baumannii Pneumonia and Sepsis. [europepmc]
- Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolated from Food-Producing Animals in Tamaulipas, Mexico. [europepmc]
- CRISPR-Based Gene Editing in Acinetobacter baumannii to Combat Antimicrobial Resistance. [europepmc]
- The overlooked bacterial pandemic. [europepmc]
- Crisis averted: a world united against the menace of multiple drug-resistant superbugs -pioneering anti-AMR vaccines, RNA interference, nanomedicine, CRISPR-based antimicrobials, bacteriophage therapies, and clinical artificial intelligence strategies to safeguard global antimicrobial arsenal. [europepmc]
- Immunopeptidomics in the Era of Single-Cell Proteomics. [europepmc]
- Two centuries of vaccination: historical and conceptual approach and future perspectives. [europepmc]
- Combating antimicrobial resistance: the silent war. [europepmc]
- Current Progress in the Development of mRNA Vaccines Against Bacterial Infections. [europepmc]
Discussions
Related